Lung Cancer Symptom Assessment and Management Intervention
| Status: | Active, not recruiting |
|---|---|
| Conditions: | Lung Cancer, Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 21 - Any |
| Updated: | 4/21/2016 |
| Start Date: | May 2008 |
| End Date: | June 2016 |
The purpose of this study is to develop and test the usability of a computerized symptom
assessment and management intervention system in a laboratory setting (phase I) and its
feasibility in a clinical setting in a group randomized trial (phase II).
assessment and management intervention system in a laboratory setting (phase I) and its
feasibility in a clinical setting in a group randomized trial (phase II).
Inclusion Criteria:
- HCPs: attending physician, thoracic medical oncologist, expected to work in the
setting for at least 2 years.
- Patients: 21 years of age or older; diagnosis of Stage IIIA, IIIB, IV non-small cell
lung cancer OR limited or extensive stage small cell lung cancer; receiving care in
the out-patient setting; receiving treatment with chemotherapy +/- additional
therapies; English speaking.
Exclusion Criteria:
- Patients: Any patient who needs emergent care, routine visits scheduled less than
once a month
We found this trial at
2
sites
Dana-Farber Cancer Institute Since it’s founding in 1947, Dana-Farber has been committed to providing adults...
Click here to add this to my saved trials
Click here to add this to my saved trials